Interpace Biosciences Statistics
Total Valuation
IDXG has a market cap or net worth of 60.94 million. The enterprise value is 59.62 million.
| Market Cap | 60.94M |
| Enterprise Value | 59.62M |
Important Dates
The last earnings date was Tuesday, April 14, 2026.
| Earnings Date | Apr 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
IDXG has 27.70 million shares outstanding. The number of shares has increased by 76.02% in one year.
| Current Share Class | 27.70M |
| Shares Outstanding | 27.70M |
| Shares Change (YoY) | +76.02% |
| Shares Change (QoQ) | +0.04% |
| Owned by Insiders (%) | 3.49% |
| Owned by Institutions (%) | 0.52% |
| Float | 3.47M |
Valuation Ratios
The trailing PE ratio is 2.44.
| PE Ratio | 2.44 |
| Forward PE | n/a |
| PS Ratio | 1.57 |
| PB Ratio | 2.73 |
| P/TBV Ratio | 2.73 |
| P/FCF Ratio | 11.13 |
| P/OCF Ratio | 10.45 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.26, with an EV/FCF ratio of 10.89.
| EV / Earnings | 2.43 |
| EV / Sales | 1.54 |
| EV / EBITDA | 10.26 |
| EV / EBIT | 12.46 |
| EV / FCF | 10.89 |
Financial Position
The company has a current ratio of 1.94, with a Debt / Equity ratio of 0.05.
| Current Ratio | 1.94 |
| Quick Ratio | 1.60 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | 0.20 |
| Debt / FCF | 0.22 |
| Interest Coverage | 28.48 |
Financial Efficiency
Return on equity (ROE) is 248.03% and return on invested capital (ROIC) is 44.34%.
| Return on Equity (ROE) | 248.03% |
| Return on Assets (ROA) | 12.30% |
| Return on Invested Capital (ROIC) | 44.34% |
| Return on Capital Employed (ROCE) | 16.65% |
| Weighted Average Cost of Capital (WACC) | 9.62% |
| Revenue Per Employee | 379,686 |
| Profits Per Employee | 240,931 |
| Employee Count | 102 |
| Asset Turnover | 1.59 |
| Inventory Turnover | 12.56 |
Taxes
| Income Tax | -21.21M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +88.03% in the last 52 weeks. The beta is 0.97, so IDXG's price volatility has been similar to the market average.
| Beta (5Y) | 0.97 |
| 52-Week Price Change | +88.03% |
| 50-Day Moving Average | 1.84 |
| 200-Day Moving Average | 1.18 |
| Relative Strength Index (RSI) | 68.59 |
| Average Volume (20 Days) | 5,984 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.56 |
Income Statement
In the last 12 months, IDXG had revenue of 38.73 million and earned 24.58 million in profits. Earnings per share was 0.89.
| Revenue | 38.73M |
| Gross Profit | 24.13M |
| Operating Income | 4.78M |
| Pretax Income | 3.77M |
| Net Income | 24.58M |
| EBITDA | 5.21M |
| EBIT | 4.78M |
| Earnings Per Share (EPS) | 0.89 |
Balance Sheet
The company has 2.51 million in cash and 1.18 million in debt, with a net cash position of 1.32 million or 0.05 per share.
| Cash & Cash Equivalents | 2.51M |
| Total Debt | 1.18M |
| Net Cash | 1.32M |
| Net Cash Per Share | 0.05 |
| Equity (Book Value) | 22.36M |
| Book Value Per Share | 4.93 |
| Working Capital | 4.80M |
Cash Flow
In the last 12 months, operating cash flow was 5.83 million and capital expenditures -356,000, giving a free cash flow of 5.48 million.
| Operating Cash Flow | 5.83M |
| Capital Expenditures | -356,000 |
| Depreciation & Amortization | 425,000 |
| Net Borrowing | -4.40M |
| Free Cash Flow | 5.48M |
| FCF Per Share | 0.20 |
Margins
Gross margin is 62.31%, with operating and profit margins of 12.35% and 63.46%.
| Gross Margin | 62.31% |
| Operating Margin | 12.35% |
| Pretax Margin | 9.74% |
| Profit Margin | 63.46% |
| EBITDA Margin | 13.45% |
| EBIT Margin | 12.35% |
| FCF Margin | 14.14% |
Dividends & Yields
IDXG does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -76.02% |
| Shareholder Yield | -76.02% |
| Earnings Yield | 40.33% |
| FCF Yield | 8.98% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on January 15, 2020. It was a reverse split with a ratio of 0.1.
| Last Split Date | Jan 15, 2020 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
IDXG has an Altman Z-Score of -6.71 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -6.71 |
| Piotroski F-Score | 4 |